BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20423711)

  • 1. ATP and the pathogenesis of COPD.
    Mortaz E; Folkerts G; Nijkamp FP; Henricks PA
    Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP in the pathogenesis of lung emphysema.
    Mortaz E; Braber S; Nazary M; Givi ME; Nijkamp FP; Folkerts G
    Eur J Pharmacol; 2009 Oct; 619(1-3):92-6. PubMed ID: 19654006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema.
    Cicko S; Lucattelli M; Müller T; Lommatzsch M; De Cunto G; Cardini S; Sundas W; Grimm M; Zeiser R; Dürk T; Zissel G; Boeynaems JM; Sorichter S; Ferrari D; Di Virgilio F; Virchow JC; Lungarella G; Idzko M
    J Immunol; 2010 Jul; 185(1):688-97. PubMed ID: 20519655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells.
    Idzko M; Hammad H; van Nimwegen M; Kool M; Willart MA; Muskens F; Hoogsteden HC; Luttmann W; Ferrari D; Di Virgilio F; Virchow JC; Lambrecht BN
    Nat Med; 2007 Aug; 13(8):913-9. PubMed ID: 17632526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of P2X receptors and Ca2+ sensitization in extracellular adenosine triphosphate-induced hyperresponsiveness in airway smooth muscle.
    Oguma T; Ito S; Kondo M; Makino Y; Shimokata K; Honjo H; Kamiya K; Kume H
    Clin Exp Allergy; 2007 Jun; 37(6):893-900. PubMed ID: 17517103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.
    Lommatzsch M; Cicko S; Müller T; Lucattelli M; Bratke K; Stoll P; Grimm M; Dürk T; Zissel G; Ferrari D; Di Virgilio F; Sorichter S; Lungarella G; Virchow JC; Idzko M
    Am J Respir Crit Care Med; 2010 May; 181(9):928-34. PubMed ID: 20093639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema.
    Lucattelli M; Cicko S; Müller T; Lommatzsch M; De Cunto G; Cardini S; Sundas W; Grimm M; Zeiser R; Dürk T; Zissel G; Sorichter S; Ferrari D; Di Virgilio F; Virchow JC; Lungarella G; Idzko M
    Am J Respir Cell Mol Biol; 2011 Mar; 44(3):423-9. PubMed ID: 20508069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of inflammatory mechanisms in asthma and COPD.
    Ichinose M
    Allergol Int; 2009 Sep; 58(3):307-13. PubMed ID: 19628975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
    Apolloni S; Montilli C; Finocchi P; Amadio S
    FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
    Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
    Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil in chronic obstructive pulmonary disease.
    Quint JK; Wedzicha JA
    J Allergy Clin Immunol; 2007 May; 119(5):1065-71. PubMed ID: 17270263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases.
    Pelleg A; Schulman ES; Barnes PJ
    Chest; 2016 Oct; 150(4):908-915. PubMed ID: 27568579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP is a mediator of chemosensory transduction in the central nervous system.
    Gourine AV; Llaudet E; Dale N; Spyer KM
    Nature; 2005 Jul; 436(7047):108-11. PubMed ID: 16001070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells.
    Czajkowski R; Barańska J
    Acta Biochim Pol; 2002; 49(4):877-89. PubMed ID: 12545194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
    Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effect of extracellular ATP on human and rat airways is due to multiple P2 purinoceptor activation.
    Mounkaïla B; Marthan R; Roux E
    Respir Res; 2005 Dec; 6(1):143. PubMed ID: 16336659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease.
    Ahmad S; Ahmad A; White CW
    Free Radic Biol Med; 2006 Jul; 41(1):29-40. PubMed ID: 16781450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X receptors as cell-surface ATP sensors in health and disease.
    Khakh BS; North RA
    Nature; 2006 Aug; 442(7102):527-32. PubMed ID: 16885977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.